You were told the shot would help. Nobody told you for how long.
If you have knee arthritis in Oklahoma City, you have probably been offered a cortisone injection and a prescription for an anti-inflammatory. Somewhere in that process you started reading about ozone injections, and what you found was a mess: clinic pages saying ozone outperforms steroids, message boards saying it did nothing, and a few people insisting it changed their life.
Three analyses published in 2026 explain why all of those people can be telling the truth. The evidence on ozone for knee osteoarthritis is not really split on whether it works. It is split on what you compare it to and how long you wait before you measure.
What an ozone knee injection actually is
Medical ozone is a gas made from oxygen. In an intra-articular ozone injection, a measured, diluted amount of that gas is injected into the joint space itself. Venturis Clinic also offers prolozone, which layers ozone with a local anesthetic and nutrients in the same visit, alongside a broader range of ozone therapy services.
The proposed mechanism is not that ozone rebuilds cartilage. It is that ozone briefly changes the chemical environment inside the joint, which appears to dial down inflammatory signaling and reduce pain. And to be plain up front: ozone therapy is not approved by the U.S. Food and Drug Administration for treating knee osteoarthritis. Any clinic implying otherwise is not being straight with you.
The 2026 finding that gets quoted: ozone held its own against cortisone
A systematic review and meta-analysis published in Medical Gas Research in 2026 asked a narrow, practical question: how do intra-articular ozone injections compare with intra-articular corticosteroid injections in knee osteoarthritis? The authors pooled seven controlled clinical trials covering 409 people. Ozone injections were more effective than corticosteroid injections at reducing pain in the short and medium terms, and medium-term function improvement also favored ozone.
The same authors said something the clinic pages quoting this study tend to leave out: definitive conclusions could not be drawn, because the quality of the included trials was limited, and better trials are needed to confirm the result. That caveat is theirs, not ours, and it belongs in the same breath as the headline.
The 2026 finding almost nobody quotes: the effect has a shelf life
A second systematic review and meta-analysis, published in Frontiers in Pain Research in 2026, asked a different question: not whether ozone works, but how long the benefit lasts. The authors pooled 16 randomized controlled trials covering 1,172 patients and sorted the results by follow-up time point.
The pattern is specific. WOMAC total scores improved at one month. At two months, WOMAC pain, WOMAC function, and VAS pain scores all improved significantly. At three months, no statistically significant differences were observed in any outcome. At six and twelve months, the ozone group scored significantly worse than the comparison group on several outcomes.
The authors summarize it as a benefit peaking around two months, diminishing by three, and very weakly supported at six to twelve months, with active comparators such as hyaluronic acid doing better at those later points. They call for placebo-controlled long-term trials and studies of repeated dosing before anyone recommends repeat injections as routine.
Why the two studies do not actually contradict each other
Side by side these look like a fight. They are not. The first compared ozone against a steroid shot over short and medium term outcomes, the window where ozone performs. The second followed patients out to a year against a range of active treatments, the window where ozone fades. Both can be true at once, and together they say something useful: ozone appears to be a fast, short-acting intervention, not a durable one. Judged as a way to get relief over the next several weeks, it looks reasonable. Judged as a once-a-year fix, it does not hold up, and you should be skeptical of anyone selling it that way.
Would a stronger dose last longer? The 2026 data says probably not
The natural next thought is that the effect fades because the dose is too small. A 2026 retrospective cohort study in the Journal of Pain Research looked directly at that: 45 patients aged 40 to 80 with Kellgren-Lawrence grade II to III knee osteoarthritis, grouped by the ozone concentration in their records at 1, 5, or 10 micrograms per milliliter, all receiving weekly injections for three consecutive weeks with outcomes measured at week four.
Pain and function improved significantly in all three groups, with no significant differences between groups in pain, stiffness, physical function, or total scores. The only between-group difference that reached significance ran the other direction: improvement in two-minute walking distance was greater in the lowest concentration group than in the highest. No adverse events were documented in any group.
The authors are careful, and so are we: this was a small retrospective study, causal conclusions cannot be drawn from it, and they call the walking-distance finding exploratory. But it points the same way as the platelet dose research behind our piece on why PRP results vary: dose behaves like a window, not a ladder. A clinic selling a higher concentration as a premium upgrade is making a claim the evidence does not support.
Why ozone fades, and what that means for planning
A 2026 narrative review in Gels placed several joint injection therapies on a single timeline based on how long each physically persists and stays biologically active in the joint. Ozone sits at the shortest end of that spectrum; conventional hyaluronic acid shows intermediate persistence, and platelet-rich plasma and injectable platelet-rich fibrin provide more sustained biological signaling. Its authors are explicit that this describes duration, not a ranking of efficacy, and a narrative review carries less weight than the two meta-analyses above. But it explains the time-course data: a gas that briefly changes the joint environment has a shorter runway than something that stays in the joint or delivers ongoing biological signals.
Practically, that reframes the question from ozone or something else to what am I trying to accomplish, and over what time frame. Ozone may be a reasonable option for someone who needs a window of reduced pain to get through a course of rehabilitation, or who wants to avoid another round of steroid. Results vary.
Who is generally not a good candidate
Being honest about this is more useful than another testimonial. Intra-articular ozone is generally not the right starting point for:
- Anyone with G6PD deficiency. A standard contraindication for ozone therapy, worth knowing before you book anything.
- People with end-stage, bone-on-bone joint changes. The research above studied mostly earlier-grade osteoarthritis, and a short-acting anti-inflammatory effect has little to work with in a joint that has lost its cartilage.
- Anyone with an active joint infection, a bleeding disorder, or uncontrolled clotting concerns.
- Someone looking for a single durable solution. If the goal is one injection that lasts a year, the time-course data says ozone is the wrong tool, and we would rather tell you now.
- Anyone whose knee has not been properly evaluated. Meniscal, ligamentous, referred hip, and inflammatory-arthritis causes of knee pain all get missed, and injecting the joint does not fix any of them.
Candidates are typically evaluated during a consultation that includes history, imaging, and examination. Pregnancy, active cancer treatment, and certain cardiac and respiratory conditions also require individual review before any ozone therapy.
What to ask before you book an ozone injection in Oklahoma City
- What concentration and volume are you using, and why that one?
- How many sessions, spaced how far apart, before we decide whether it worked?
- At what point do you measure the result, and with what scale?
- Is the injection guided by ultrasound, or placed by landmark?
- What is the plan if I get two good months and then it fades?
- What else in my plan is doing the durable work, such as strengthening or load management?
Frequently asked questions
How long does an ozone knee injection last?
In the 2026 Frontiers in Pain Research meta-analysis of 16 randomized trials, benefit appeared at one month, peaked around two months, and was no longer statistically significant by three months. Individual results vary, but two to three months is the honest answer, not a year.
Is ozone better than a cortisone shot for knee arthritis?
The 2026 Medical Gas Research meta-analysis of seven trials found ozone more effective than corticosteroid for pain in the short and medium terms, and better for medium-term function. The same authors noted the underlying trials were of limited quality, so this is a promising signal rather than a settled conclusion.
Is ozone therapy FDA approved for knee osteoarthritis?
No. Ozone therapy is not FDA approved for treating knee osteoarthritis, and prolozone is likewise investigational. That does not mean it is unstudied, but expect a clinic to say so plainly.
Does a higher ozone concentration work better?
Current evidence does not support that. A 2026 retrospective study comparing 1, 5, and 10 micrograms per milliliter found no significant differences between groups in pain, stiffness, or function, and the lowest concentration group improved most on a two-minute walking test. It was small and exploratory, but nothing in it supports paying more for a stronger dose.
How many ozone injections will I need?
Published protocols commonly use a short series, often three injections about a week apart, followed by reassessment. The 2026 reviews called for more research on repeated dosing before repeat injections become routine, so a schedule should be set during an evaluation rather than sold as a package up front.
Does an ozone knee injection hurt?
Patients commonly describe pressure and a brief ache as the joint is filled, followed by soreness for a day or two. Prolozone includes a local anesthetic. Some report same-day relief and some feel worse for a day first; both are within the normal range.
Talk with someone who will tell you what the research actually says
Dr. Alvin Philipose, DC, ICCP, has spent more than 25 years in regenerative and functional medicine and has performed thousands of prolotherapy procedures. If you are weighing an ozone injection for knee arthritis, the useful next step is an evaluation of the knee itself.
Venturis Clinic
7917 N May Ave, Suite B
Oklahoma City, OK 73120
(405) 848-7246
Request an appointment, or book a free 15-minute phone consultation to ask whether this is a reasonable fit.
This content is for educational purposes only and is not medical advice, diagnosis, or treatment. Individual results vary and no outcome is guaranteed. Venturis Clinic offers regenerative, functional, and alternative medicine services; some therapies discussed are not FDA-approved for the uses described. Talk with a qualified healthcare provider about your specific situation before beginning any treatment.
Sources
- Ozone injections reduce pain in knee osteoarthritis: a systematic review and meta-analysis. Medical Gas Research, 2026;16(3):286-292. DOI: 10.4103/mgr.MEDGASRES-D-25-00088
- The time-effect relationship of intra-articular ozone injection for knee osteoarthritis: a systematic review and meta-analysis. Frontiers in Pain Research, 2026;7:1843756. DOI: 10.3389/fpain.2026.1843756
- Dinc Yavas A, Akcay S. Comparative Effectiveness of Low-Dose Intra-Articular Ozone Therapy for Pain and Functional Outcomes in Patients with Knee Osteoarthritis: A Retrospective Cohort Study. Journal of Pain Research, 2026;19:637872. DOI: 10.2147/JPR.S637872
- Costa FR, Martins R, Protasio Netto J, et al. Temporal Hierarchy of Hydrogels and Orthobiologic Therapies for Knee Osteoarthritis. Gels, 2026;12(7):608. DOI: 10.3390/gels12070608
Citations located via PubMed.
